Literature DB >> 10973383

One hundred consecutive minimally invasive parathyroid explorations.

R Udelsman1, P I Donovan, L J Sokoll.   

Abstract

OBJECTIVE: To review the outcomes of 100 consecutive minimally invasive parathyroid explorations. SUMMARY BACKGROUND DATA: Minimally invasive parathyroidectomy (MIP) has challenged the traditional approach of bilateral neck exploration for patients with primary hyperparathyroidism. Most patients with primary hyperparathyroidism have a single adenoma that when resected results in cure. It therefore appears logical to perform a directed approach to adenoma extirpation. MIP involves high-quality sestamibi images obtained with single photon emission computed tomography to localize enlarged parathyroid glands in three dimensions, limited exploration after surgeon-administered cervical block anesthesia, rapid intraoperative parathyroid hormone assay to confirm the adequacy of resection, and discharge within 1 to 3 hours of surgery.
METHODS: MIP was offered to 100 selected consecutive patients during an 18-month period beginning in March 1998.
RESULTS: Ninety-two cases were accomplished under cervical block anesthesia and 89 of these on an ambulatory basis. The cure rate was 100%, and there were no long-term complications. The mean hospital charge for MIP was less than 40% of that associated with traditional exploration.
CONCLUSIONS: Outpatient MIP appears to be the procedure of choice for most patients with primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973383      PMCID: PMC1421147          DOI: 10.1097/00000658-200009000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay.

Authors:  H Chen; L J Sokoll; R Udelsman
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

2.  Secondary hyperparathyroidism is an expected consequence of parathyroidectomy for primary hyperparathyroidism: a prospective study.

Authors:  A K Mandal; R Udelsman
Journal:  Surgery       Date:  1998-12       Impact factor: 3.982

3.  The glandulae parathyroideae of Ivar Sandström. Contributions from two continents.

Authors:  J A Carney
Journal:  Am J Surg Pathol       Date:  1996-09       Impact factor: 6.394

4.  Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section.

Authors:  W H Westra; D D Pritchett; R Udelsman
Journal:  Am J Surg Pathol       Date:  1998-05       Impact factor: 6.394

5.  Surgical management of primary hyperparathyroidism.

Authors:  C A Wang
Journal:  Curr Probl Surg       Date:  1985-11       Impact factor: 1.909

6.  Recovery of parathyroid hormone secretion after parathyroid adenomectomy.

Authors:  A R Brasier; C A Wang; S R Nussbaum
Journal:  J Clin Endocrinol Metab       Date:  1988-03       Impact factor: 5.958

7.  Parathyroidectomy in Maryland: effects of an endocrine center.

Authors:  H Chen; M A Zeiger; T A Gordon; R Udelsman
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

8.  Ambulatory parathyroidectomy for primary hyperparathyroidism.

Authors:  G L Irvin; G Sfakianakis; L Yeung; G T Deriso; L M Fishman; A S Molinari; J N Foss
Journal:  Arch Surg       Date:  1996-10

9.  A new, practical intraoperative parathyroid hormone assay.

Authors:  G L Irvin; G T Deriso
Journal:  Am J Surg       Date:  1994-11       Impact factor: 2.565

10.  Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma.

Authors:  S Tibblin; A G Bondeson; O Ljungberg
Journal:  Ann Surg       Date:  1982-03       Impact factor: 12.969

  10 in total
  55 in total

1.  Six hundred fifty-six consecutive explorations for primary hyperparathyroidism.

Authors:  Robert Udelsman
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

2.  Surgery for primary hyperparathyroidism: what is the best approach?

Authors:  Herbert Chen
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

Review 3.  Robotic transaxillary and retroauricular parathyroid surgery.

Authors:  Hossam Eldin Mohamed; Parisha Bhatia; Rizwan Aslam; Thomas Moulthrop; Emad Kandil
Journal:  Gland Surg       Date:  2015-10

4.  Unilateral surgery for hyperparathyroidism: indications, limits, and late results--new philosophy or expensive selection without improvement of surgical results?

Authors:  Pierre-E Mortier; Marta M Mozzon; Olivier P Fouquet; Benoit C Soudan; Damien G Huglo; Jean-F Cussac; Charles A G Proye
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

Review 5.  Fast-track surgery: procedure-specific aspects and future direction.

Authors:  Daniel Ansari; Luca Gianotti; Jörg Schröder; Roland Andersson
Journal:  Langenbecks Arch Surg       Date:  2012-09-27       Impact factor: 3.445

6.  Focused approach to parathyroidectomy.

Authors:  Tobias Carling; Robert Udelsman
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  1112 consecutive bilateral neck explorations for primary hyperparathyroidism.

Authors:  John Allendorf; Mary DiGorgi; Kathryn Spanknebel; William Inabnet; John Chabot; Paul Logerfo
Journal:  World J Surg       Date:  2007-08-31       Impact factor: 3.352

8.  Does levothyroxine administration impact parathyroid localization?

Authors:  Rachell R Ayers; Kirby Tobin; Rebecca S Sippel; Courtney Balentine; Dawn Elfenbein; Herbert Chen; David F Schneider
Journal:  J Surg Res       Date:  2015-03-31       Impact factor: 2.192

9.  Comparison of consumer information on the internet to the current evidence base for minimally invasive parathyroidectomy.

Authors:  Timothy McLean; Leigh Delbridge
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

10.  Cost-effectiveness of scan-directed parathyroidectomy.

Authors:  Radu Mihai; Mary Weisters; Michael J Stechman; Fergus Gleeson; Greg Sadler
Journal:  Langenbecks Arch Surg       Date:  2008-08-01       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.